P58 (Docusate 240 mg)
Pill imprint P58 has been identified as Docusate calcium 240 mg.
Docusate is used in the treatment of constipation and belongs to the drug class laxatives. FDA has not classified the drug for risk during pregnancy. Docusate 240 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 240 mg
- Rx and/or OTC
- Drug Class:
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|00536-3755||Rugby Laboratories Inc.|
|68115-0807||Dispensexpress Inc (repackager)|
|55887-0964||Diversified Healthcare Services Inc (repackager)|
|00490-0078||Southwood Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about docusate
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.